This Analyst Loves Depomed And Its Nucynta Prescription By: Benzinga via Benzinga August 28, 2015 at 15:28 PM EDT In a report issued Friday, Roth Capital analyst Scott R. Henry provided an update of prescriptions for Nucynta, a franchise recently ... Read More >> Related Stocks: Bio-Techne Corp Depomed Inc Horizon Therapeutics